• Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues


Bayer Begins Research At Its Southeast Cotton Breeding Facility In Dawson, Georgia

Bayer is ready to begin extensive research and development at its recently opened $4.4 million, 150-acre, Southeast cotton breeding facility built in Dawson, Georgia.

According to company officials, the innovative facility builds on a proven history of profitable cotton varieties brought to market through its Stoneville and FiberMax brands. This week the facility celebrated the harvest of its first research crop.

"We're so proud to be here opening this incredible new facility, as this inauguration represents a significant investment for Georgia and a clear commitment to Bayer's investment in advancing technology across cotton," said Monty Christian, Bayer Vice President for U.S. Cotton Operations. "We will continue here with Bayer's proven record of delivering cotton varieties with high yield potential and high quality fiber packages, specifically through our flagship brands, Stoneville and FiberMax."

“The Southeast Cotton Breeding Station is part of Bayer's commitment to invest nearly $1 billion in the United States between 2013-2016 in new facilities and capital expansion to complement the approximately $1 billion invested globally in research and development annually,” company officials said. “The breeding and research focus here is on varieties and traits that clear agronomic hurdles and enhance both, efficiency and profitability for growers who are working to provide food, feed, fiber and renewable raw materials globally.”

"For us, it is important to continue expanding our Seeds business through R&D, and this facility will bring together significant scientific and technology resources to support the advancement of the agricultural industry, specifically for cotton seed trait and plant research," said Mike Gilbert, Vice President and Head of Global Breeding & Trait Development for Bayer.

Exclusive Research